Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic and Wegovy: Scientists Uncover New Risks of Popular Weight-Loss “Miracle Drugs”
GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and gastrointestinal issues. Demand for weight-loss medications, including popular brands like Ozempic and Wegovy,
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. | In the phase 3b STEP UP study,
Weight-loss drugs linked to unexpected benefits and risks
The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks of addiction.
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has uncovered neurological and behavioral health benefits amid risks for pancreatitis and kidney disease.
Major study of weight-loss jabs shows slew of benefits but also risks
The risk of heart attack and stroke declines, but gastrointestinal problems and joint inflammation increase: New research has shed more light on the pros and cons of weight-loss jabs.
Weight-Loss Drugs Show Major Health Benefits but Carry Risks
A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy. While originally designed to treat type 2 diabetes, these medications have been linked to improved heart health fewer infections,
Researchers reveal benefits, risks linked to popular weight-loss drugs
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have rapidly emerged as game-changers in treating diabetes, heart disease, and obesity. Commonly marketed under brand names like Ozempic and Wegovy,
BioSpace
6d
Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial
Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...
2d
'I'm a GP and this is how to tell if you're being sold fake weight loss injections'
While it's illegal to sell certain substances without a prescription, it's possible that you could be sold fake weight loss ...
Diabetes.co.uk
3d
New study raises concerns over serious side effects of weight loss injections
A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...
valuepenguin
10d
Costs and Insurance Coverage for Ozempic, Wegovy & Weight Loss Drugs
Ozempic has been approved for diabetes, though it's sometimes still used
for weight
loss
. Rybelsus is a similar drug that's the same price and uses the same ingredient as Ozempic. But Rybelsus is ...
Metro Times
13d
What Is the Ideal Semaglutide Dose for Weight Loss?
The best semaglutide dose for weight loss varies according to your starting weight, risks, and stage of treatment. Read to ...
6d
Mounjaro vs. Ozempic: Which One Is Best for Me to Try for Weight Loss in 2025?
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
3d
‘Hundreds in hospital with serious reaction to fat loss jabs’ as half a million Brits using injections to shed pounds’
EXPERTS have warned over hundreds rushed to hospital after using weight loss jabs – as half a million Brits now use the ...
4d
on MSN
Black-market weight drugs put hundreds in hospital with diarrhoea and vomiting
Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback